Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
K. Kian Ang(National University of Singapore), Charles D. Wendt(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center), Moshe Maor(Reichman University), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Lester J. Peters(Peter MacCallum Cancer Centre)
International Journal of Radiation Oncology*Biology*Physics
December 1, 1990
Cited by 236
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741